MENU
AUPH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Aurinia Pharmaceuticals (AUPH) Ownership - Who owns Aurinia Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
14315 118 Avenue
Phone
+1 250 708-4272
Employees
300
Web
https://www.auriniapharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.37B
P/E Ratio
N/A
Total Cash
348.75M
Projected Growth
N/A
Total Debt
87.85M
Revenue
220.36M
Risk (Beta)
1.77
Dividend Yield
N/A
Total Cash/Share
2.44
Total Debt/Equity
N/A
Revenue/Share
1.52 USD as % of share price
Fundamentals
AUPH
Capitalization
1.37B
P/E Ratio
N/A
Risk (Beta)
1.77
Dividend Yield
N/A
Total Cash
349M
Total Cash/Share
2.44
Total Debt
87.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.52%
Revenue
220M
ROE
N/A
Book Value
388M
P/B Ratio
3.55
Cash Flow
N/A
Earnings
-0.15
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.21B
Current Ratio
5.60
Current Revenue Per Employee
225903.33
Dividends Per Share - Security
N/A
EBITDA
4.39M
Float
N/A
Float - Current
N/A
Gross Income Margin
91.09
Revenue To Assets
-4.08
Shares Held By Institutions
501M
Shares Outstanding - Current
143M
Total Liabilities
161M
Total Volume MTD
N/A
Value
N/A
Gain YTD
6.229
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
14315 118 Avenue
Phone
+1 250 708-4272
Employees
300
Web
https://www.auriniapharma.com